- Home
- MU vs NVS Comparison
MU vs NVS Comparison
Compare MU & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MU | NVS |
|---|---|---|
| Founded | 1978 | 1895 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.0B | 254.8B |
| IPO Year | N/A | 1991 |
Fundamental Metrics
Financial Performance| Metric | MU | NVS |
|---|---|---|
| Price | $258.92 | $131.09 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 32 | 4 |
| Target Price | ★ $215.81 | $118.00 |
| AVG Volume (30 Days) | ★ 25.5M | 1.7M |
| Earning Date | 12-17-2025 | 10-28-2025 |
| Dividend Yield | 0.18% | ★ 1.98% |
| EPS Growth | ★ 984.29 | N/A |
| EPS | ★ 7.59 | 7.30 |
| Revenue | $37,378,000,000.00 | ★ $56,372,000,000.00 |
| Revenue This Year | $50.61 | $9.33 |
| Revenue Next Year | $16.26 | $2.75 |
| P/E Ratio | $33.26 | ★ $17.95 |
| Revenue Growth | ★ 48.85 | 12.88 |
| 52 Week Low | $61.54 | $96.06 |
| 52 Week High | $260.58 | $134.24 |
Technical Indicators
Market Signals| Indicator | MU | NVS |
|---|---|---|
| Relative Strength Index (RSI) | 64.43 | 53.87 |
| Support Level | $223.33 | $129.98 |
| Resistance Level | $244.37 | $133.16 |
| Average True Range (ATR) | 11.88 | 1.77 |
| MACD | 1.46 | 0.10 |
| Stochastic Oscillator | 99.55 | 71.14 |
Price Performance
Historical ComparisonAbout MU Micron Technology Inc.
Micron is one of the largest semiconductor companies in the world, specializing in memory and storage chips. Its primary revenue stream comes from dynamic random access memory, or DRAM, and it also has minority exposure to not-and or NAND, flash chips. Micron serves a global customer base, selling chips into data centers, mobile phones, consumer electronics, and industrial and automotive applications. The firm is vertically integrated.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.